Quantcast

Latest Enoxaparin sodium Stories

2014-05-22 08:28:45

Seven-fold lower incidence of VTEs in patients treated with ISIS-FXIRx compared to enoxaparin CARLSBAD, Calif., May 22, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive top-line data from a Phase 2 comparator-controlled study evaluating the incidence of venous thrombolic events (VTE) in patients treated with ISIS-FXI(Rx) undergoing total knee replacement surgery, or total knee arthroplasty (TKA). ISIS-FXI(Rx) inhibits the production of Factor...

2014-05-06 08:33:03

ALBANY, New York, May 6, 2014 /PRNewswire/ -- MRRBIZ includes new market research report "Disposable Gloves Market For Medical and Non-Medical (Food, Cleanroom, Industrial And Other) Applications - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2013 - 2019" to its large collection of research report. The global market for disposable gloves is primarily driven by the growing healthcare industry and increasing awareness of hygiene among patients as...

2014-03-28 08:22:23

DUBLIN, Mar. 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/xvt3hx/investigation ) has announced the addition of the "Investigation Report on China Enoxaparin Sodium Market, 2009-2018" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. It can result in anoxia, the complete deprivation of...

2014-03-03 23:02:09

Despite the FDA's recent rejection of Xarelto, Dr. Henry Mentz and the Aesthetic Center for Plastic Surgery plan to continue research. Houston, TX (PRWEB) March 03, 2014 Last month, the FDA denied approval of new uses for Johnson & Johnson’s blood thinning drug Xarelto. Dr. Mentz, of the Aesthetic Center for Plastic Surgery, will still continue his research on the drug, however. Xarelto was seeking clearance to treat patients with acute coronary syndrome (ACS) when it was...

2012-05-23 20:44:01

Third round of improvements to blood thinner standard announced by USP To help further secure a safe supply of the widely—used blood thinner heparin, a third round of revisions to quality standards for the drug has been advanced by the U.S. Pharmacopeial Convention (USP). USP's Expert Panel on Unfractionated Heparin ended a two-day meeting on May 16th, 2012, and recommended finalization of the proposed changes. The revisions are scheduled to appear in the November—December 2012...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related